FDA issues warnings to Web sites over drug sales
NEW YORK — The Food and Drug Administration said Thursday it issued 22 warning letters to Web site operators over alleged illegal sales of unapproved or misbranded drugs.
The agency said the move caps a weeklong international effort aimed at curbing illegal actions regarding medical products, including sales. In all, the FDA and its partners in the program targeted 136 Web sites that appeared to be illegally selling medical products.
None of the Web sites were for pharmacies in the U.S. or Canada, the agency said.
